Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours

Status

Suspended

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00991601

Enrollment

150

Registered

2009-10-08

Start date

2009-07-31

Completion date

2011-12-31

Last updated

2010-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumors in Liver, Tumors in Pancreas

Keywords

liver, pancreas, cancer, tumor, FNAC

Brief summary

Patients with tumors in liver or pancreas are randomized to ultrasound (UL)-guided FNAC biopsies with guidance method or UL-guided FNAC biopsies with free-hand method.

Interventions

PROCEDUREFNAC (fine needle aspiration cytology)

UL guided biopsy

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* adult over 18 years * tumors in liver and/or pancreas

Exclusion criteria

* low coagulation factors * mentally ill patients.

Design outcomes

Primary

Measure	Time frame
quality of obtained biopsy	one year

Secondary

Measure	Time frame
patients pain and discomfort at procedure	immediately

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026